Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
Edelmann F, Musial-Bright L, Gelbrich G, Trippel T, Radenovic S, Wachter R, Inkrot S, Loncar G, Tahirovic E, Celic V, Veskovic J, Zdravkovic M, Lainscak M, Apostolović S, Neskovic AN, Pieske B, Düngen HD; CIBIS-ELD Investigators and Project Multicenter Trials in the Competence Network Heart Failure.
Edelmann F, et al. Among authors: musial bright l.
JACC Heart Fail. 2016 Feb;4(2):140-149. doi: 10.1016/j.jchf.2015.10.008. Epub 2015 Dec 9.
JACC Heart Fail. 2016.
PMID: 26682793
Free article.
Clinical Trial.